Therefore, the authors of the study hypothesised that these findings may represent a possible novel therapy, through the utilisation of ATA to reverse the impaired NR4A1-dependent insulin signalling and lower the blood glucose levels in patients with T2DM [110]. The gene discussed is INS; the disease is type 2 diabetes mellitus.